Results 161 to 170 of about 3,709,556 (294)
Targetable Vulnerabilities in MYC‐Driven B Cell Lymphomas Resistant to BCR Extinction
ABSTRACT Polatuzumab vedotin, an antibody‐drug conjugate (ADC) targeting the B cell receptor (BCR) signaling subunit CD79B, has recently entered frontline therapy for diffuse large B cell lymphoma (DLBCL) and high‐grade B cell lymphoma (HGBCL), achieving encouraging clinical results. However, MYC‐driven B cell lymphomas, particularly HGBCL with MYC and
Silvia Brambillasca +15 more
wiley +1 more source
ABSTRACT Background As a chronic musculoskeletal disorder, intervertebral disc degeneration (IDD) is a leading cause of low back pain. Inflammatory response plays a key role in the IDD progression. Albiflorin (AF), a bioactive compound derived from Paeonia lactiflora, exhibits anti‐inflammatory effects in various diseases. However, the effects of AF on
Kai Yang, Yanping Cheng, Dan Yang
wiley +1 more source
Post-COVID-19 subacute painless thyroiditis: a case report in an anabolic androgenic steroid user. [PDF]
Skrzypiec-Spring M +3 more
europepmc +1 more source
Effects of anabolic agents on protein breakdown in L6 myoblasts.
F. Ballard, G. Francis
semanticscholar +1 more source
Knee osteoarthritis (OA) is characterized by progressive cartilage degeneration and remains a major cause of joint dysfunction with limited disease‐modifying therapies. This study evaluated the therapeutic potential of sulfated galactans (SG) extracted from Gracilaria fisheri in a rat OA model induced by anterior cruciate ligament transection and ...
Nirada Srianake +8 more
wiley +1 more source
Asian Federation of Osteoporosis Societies 2025 consensus on atypical femoral fractures in patients with osteoporosis. [PDF]
Valleenukul T +24 more
europepmc +1 more source
Cancer Comorbidities: Clinical Impacts, Mechanistic Insights, and Management Strategies
This review focuses on cancer comorbidities, examining their clinical impacts and mechanistic insights. It further examines key management challenges, including evidence gaps, the lack of precise assessment tools, limited management frameworks, and underdeveloped multidisciplinary collaborations.
Taoxing Peng +15 more
wiley +1 more source
Abaloparatide and paclitaxel combination therapy Improves bone volume and tumor burden in Bone-Metastatic breast cancer. [PDF]
Miller JS +6 more
europepmc +1 more source
Ageing acts as a double‐edged sword in cancer. In the elderly, open chromatin, immunosenescence, and chronic inflammation drive SASP (IL‐6, MMPs), MDSC accumulation and T‐cell suppression, fostering tumor‐promoting microenvironments and limited therapeutic benefit.
Qi Wang +7 more
wiley +1 more source
Bone Optimization for Perioperative Spine Patients: A Multidisciplinary Approach at a Single Academic Center. [PDF]
Suarez-Nieto MV +6 more
europepmc +1 more source

